Satellos Bioscience Inc. (MSLE)

Satellos Bioscience Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Year Ending	Current	Dec 31, 2024	Dec 31, 2023
Net Debt / Equity Ratio	-	-1.03	-0.97
Net Debt / EBITDA Ratio	-	2.37	2.32
Net Debt / FCF Ratio	-	2.80	3.41
Quick Ratio	9.88	13.55	10.92
Return on Equity (ROE)	-64.78%	-41.51%	-39.06%
Return on Assets (ROA)	-	-38.58%	-35.87%
Return on Invested Capital (ROIC)	-	-	-1427.79%
Return on Capital Employed (ROCE)	628.78%	-43.53%	-41.91%

Source: IPO financials are sourced from S-1 and S-1/A filings submitted to the Securities and Exchange Commission (SEC).